FDA Inspection 1019091 — Huntington Reproductive Center Medical Group
The FDA completed an inspection of Huntington Reproductive Center Medical Group on July 14, 2017 in Fullerton, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Fullerton, CA (United States)